The reversible inhibition of laccase by H 2 O 2 as a bioelectrocatalyst was studied in mediated-and direct electron transfer-based configurations to understand the differences in mechanism. The reversible inhibition of laccase follows a noncompetitive inhibition model when 2,2 -azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) is used as an electron mediator, whereas laccase is inhibited by an uncompetitive inhibition model when anthracene-moieties are used to intelligently "dock" laccase to electrodes (consisting of multi-walled carbon nanotubes, MWCNTs) which afford direct electron transfer (DET). This further confirms the efficient orientation of laccase onto suitably-designed docking moieties for bioelectrocatalysis applications. 1-5 Along with some other MCOs (such as bilirubin oxidase, BOx), laccase contains 3 different copper centers. A type-1 copper center (T1 Cu) is proximally located within the enzyme structure and is responsible for the single-electron oxidation of phenolic-type substrates, and a further type-2 copper center (T2 Cu) and 2 further type-3 copper centers (T3 Cu) are combined in a tri-nuclear cluster (TNC), which is responsible for the 4-electron reduction of O 2 to H 2 O. Following the oxidation of substrates at the T1 Cu site, electrons are quickly and individually transferred to the TNC via a His-Cys-His tripeptide chain.6,7 Although laccase (from Trametes versicolor) is reported to optimally reduce O 2 at acidic pH (which may limit its incorporation within implantable EFCs) further complications can be found within a physiological setting, where laccase can be inhibited by Cl − (approximately 150 mM physiological concentration) via a competitive inhibition model whereby Cl − can compete against certain electron mediators at the T1 Cu site of the enzyme. 8,9 Laccase can be intelligently orientated (or "docked") onto electrode architectures whereby moieties with structural similarities to the natural substrates of laccase (oxidized at the T1 site) are incorporated on specifically-designed electrode architectures, which subsequently allow direct electron transfer (DET).2,4,10-14 Efficient mediated electron transfer (MET) has also been demonstrated using mediators such as 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) or osmium-based complexes 1,[15][16][17] and comparison between orientationally-driven DET and MET of laccase (with ABTS) has been reported, contrasting catalytic current densities that can be achieved with both electron transfer methods.18 Such electrode architectures can be capable of demonstrating increased resistance to Cl − inhibition, since the moieties used for docking can efficiently out-compete Cl − at the T1 site and therefore permit electron transfer. 9,13,19 Recent studies, however, determined that certain membrane-less EFC configurations (favorable to lower overall device cost and size) can present further problems for laccase-based biocathodes, whereby oxidoreductases utilized at EFC bioanodes (such as glucose oxidase * Electrochemical Soc...